ARCH Venture Partners

ARCH Venture Partners, established in 1986, is a U.S.-based venture capital firm with a global scope. It specializes in investing in technology companies, with a primary focus on life sciences. ARCH invests conservatively in seed rounds to mitigate risk, and then leads or co-leads subsequent financing rounds until liquidity. The firm is known for its success in commercializing technologies from academic research institutions and national laboratories, often investing in companies co-founded by scientists and entrepreneurs. ARCH has raised over $3 billion across ten funds and has invested in over 150 companies, typically committing between $50,000 and $150 million per company. It seeks a seat on the Board of Directors and maintains a presence in underserved geographic markets. ARCH's investors include corporations, pension funds, endowment funds, financial institutions, and private investors.

Jacob Bauer

Venture Partner

Reetika Bhardwaj Ph.D

Senior Associate

Luciana Borio

Venture Partner

Kristina Burow

Managing Director

Kaye Foster

Venture Partner

Sean Kendall

Principal

Jay Kocherlakota

Senior Associate

Steven Lazarus

Co-Founder and Managing Director

Mark McDonnell

Managing Director, Chief Financial and Chief Administrative Officer

Scott Minick

Venture Partner

Peter Mintun Ph.D

Associate

Ari Nowacek

Principal, Chicago

Corey Ritter

Principal

Paul Thurk

Managing Director Europe

George Scangos Ph.D

Venture Partner

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.